PA-III rat prostate adenocarcinoma cells (review)
- PMID: 1326342
PA-III rat prostate adenocarcinoma cells (review)
Abstract
PA-III is one of the four transplantable cell lines propagated in vitro in cell monolayer cultures from four spontaneously developed prostate cancer tumors in aged germfree and conventional Lobund-Wistar (L-W) rats (Pollard Model). Our data documented the presence of IGF-I and glucocorticoid but the absence of IGF-II, insulin and androgen receptors in PA-III cells. Activation of IGF-I receptors by IGF-I, IGF-II and insulin stimulated the proliferation of PA-III cells. Activation of glucocorticoid receptors by dexamethasone inhibited the proliferation of PA-III cells. PA-III cells contained urokinase-like activity and expressed the mRNA for urokinase gene which was negatively regulated by glucocorticoids. The above results suggest that PA-III cells could be a useful model for the study of glucocorticoid effects on prostate cancer cells. In addition, these data are discussed in relationship to the capacity of PA-III cells to produce the osteoblastic reaction when transplanted on L-W rat skeleton. A model outlining the putative paracrine interactions between PA-III cells and rat osteoblasts is proposed.
Similar articles
-
Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.Anticancer Res. 1997 May-Jun;17(3A):1461-5. Anticancer Res. 1997. PMID: 9179184 Review.
-
The expression of mRNA for glucocorticoid receptor gene and functional glucocorticoid receptors detected in PA-III rat prostate adenocarcinoma cells.Anticancer Res. 1992 May-Jun;12(3):899-904. Anticancer Res. 1992. PMID: 1622147
-
Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.Clin Cancer Res. 2003 Jul;9(7):2587-97. Clin Cancer Res. 2003. PMID: 12855635
-
Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases.Anticancer Res. 1993 Mar-Apr;13(2):481-6. Anticancer Res. 1993. PMID: 7685989
-
Studies on the pathogenesis of osteoblastic metastases by prostate cancer.Adv Exp Med Biol. 1992;324:165-71. doi: 10.1007/978-1-4615-3398-6_17. Adv Exp Med Biol. 1992. PMID: 1283497 Review. No abstract available.
Cited by
-
Glucocorticoid receptor function possibly modulates cell-cell interactions in osteoblastic metastases on rat skeleton.Clin Exp Metastasis. 1997 May;15(3):205-17. doi: 10.1023/a:1018413229570. Clin Exp Metastasis. 1997. PMID: 9174122
-
Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer.In Vivo. 2010 May-Jun;24(3):249-55. In Vivo. 2010. PMID: 20554995 Free PMC article.
-
Animal models of bone metastasis.Cancer Treat Res. 2004;118:47-81. doi: 10.1007/978-1-4419-9129-4_3. Cancer Treat Res. 2004. PMID: 15043188 Free PMC article. Review.
-
Animal Models of Bone Metastasis.Vet Pathol. 2015 Sep;52(5):827-41. doi: 10.1177/0300985815586223. Epub 2015 May 28. Vet Pathol. 2015. PMID: 26021553 Free PMC article. Review.
-
Rat models of bone metastases.Clin Exp Metastasis. 2005;22(8):605-14. doi: 10.1007/s10585-006-9002-5. Epub 2006 May 3. Clin Exp Metastasis. 2005. PMID: 16670964 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials